Audience: Physicians

July 1, 2026

Sustaining the Workforce: Self-Care and Professional Resilience

This session addresses burnout, secondary stress, and sustainability for frontline workers. Participants will explore individual and organizational strategies to support long-term wellness and workforce retention.

When Our Clients Age: Adapting Drug User Health for Older Adults

This webinar will help participants build practical skills for assessing and supporting older clients, including those with long-term substance use histories. Participants will explore how aging changes the way drugs affect the body, why overdose risk increases, and how common signs of substance use may present differently in older adults.

June 10, 2026

Ethical and Compassionate Pregnancy Care for People at Risk for Overdose

This webinar will explore compassionate, ethical ways to provide supportive care
during pregnancy for people at risk for overdose, with a focus on respect, dignity, and practical approaches. Highlights on how nonjudgmental, evidence-informed approaches can promote health, informed choice, and personal autonomy for both the parent and baby will also be shared.

May 28, 2026

Sex Work, Health, and Safety: Building Trust Through Community Engagement

This webinar will focus on the intersection of sex work, health access, and community safety. Participants will explore trust-building strategies and engagement approaches that support autonomy, reduce stigma, and promote safer service environments.

March 25, 2026

Creating Stigma-Free Services: Clinical Settings

This session focuses on reducing stigma in clinical settings serving people at risk of overdose, with an emphasis on improving patient experience, strengthening provider communication, and implementing systems-level changes that enhance engagement, retention in care, and overall health outcomes across Maryland.

Ketamine and Psychedelic Substances in Practice: What Providers and Communities Need to Know

This advanced session explores the evolving landscape of ketamine and other psychedelic substances as they appear in clinical settings, community conversations, and personal use. Participants will examine current evidence, emerging models of care, ethical considerations, and how providers can engage in informed, nonjudgmental conversations while navigating Maryland’s legal and clinical context.